Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
- Status
- RECRUITING
- Phase
- N/A
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
- Status
- RECRUITING
- Phase
- N/A
Mosaic Trial for Stem Cell Transplant Recipients
- Status
- RECRUITING
- Phase
- NA
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- N/A
Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Efficacy of Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Bridging Therapy Followed by Transplantation in Higher-Risk Myelodysplastic Syndrome Patients
- Status
- RECRUITING
- Phase
- PHASE2
Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States
- Status
- COMPLETED
- Phase
- N/A
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE2
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2
Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations
- Status
- RECRUITING
- Phase
- PHASE2
TMLI/Fludarabine/Melphalan Conditioning for Allogeneic Transplantation in High-risk Myelodysplastic Syndrome or Acute Myeloid Leukemia.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
TMLI Plus Chemotherapy in High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
- Status
- RECRUITING
- Phase
- PHASE1